Novel specific microRNA biomarkers in idiopathic inflammatory bowel disease unrelated to disease activity

Jingmei Lin, Noah C. Welker, Zijin Zhao, Yong Li, Jianjun Zhang, Sarah A. Reuss, Xinjun Zhang, Hwajeong Lee, Yunlong Liu, Mary P. Bronner

Research output: Contribution to journalArticlepeer-review

47 Scopus citations

Abstract

The diagnosis of idiopathic inflammatory bowel disease can be challenging. MicroRNAs (miRNAs) are small, non-coding RNAs that regulate protein synthesis through post-transcriptioal suppression. This study is to identify new miRNA markers in inflammatory bowel disease, and to examine whether miRNA biomarkers might assist in the diagnosis of inflammatory bowel disease. Illumina small RNA sequencing was performed on non-dysplastic fresh-frozen colonic mucosa samples of the distalmost colectomy tissue from 19 patients with inflammatory bowel disease (10 ulcerative colitis and 9 Crohn disease) and 18 patients with diverticular disease serving as controls. To determine differentially expressed miRNAs, the USeq software package identified 44 miRNAs with altered expression (fold change ≥2 and false discovery rate ≤0.10) compared with the controls. Among them, a panel of nine miRNAs was aberrantly expressed in both ulcerative colitis and Crohn disease. Validation assays performed using quantitative reverse transcription PCR (qRT-PCR) on additional frozen tissue from ulcerative colitis, Crohn disease, and control groups confirmed specific differential expression in inflammatory bowel disease for miR-31, miR-206, miR-424, and miR-146a (P<0.05). The expression of these four miRNAs was further evaluated on formalin-fixed, paraffin-embedded tissue of the distalmost colectomy mucosa from cohorts of diverticular disease controls (n=29), ulcerative colitis (n=36), Crohn disease (n=26), and the other diseases mimicking inflammatory bowel disease including infectious colitis (n=12) and chronic ischemic colitis (n=19), again confirming increased expression specific to inflammatory bowel disease (P<0.05). In summary, we demonstrate that miR-31, miR-206, miR-424, and miR-146a are novel specific biomarkers of inflammatory bowel disease. Furthermore, miR-31 is universally expressed in both ulcerative colitis and Crohn disease not only in fresh-frozen but also in formalin-fixed, paraffin-embedded tissues.

Original languageEnglish (US)
Pages (from-to)602-608
Number of pages7
JournalModern Pathology
Volume27
Issue number4
DOIs
StatePublished - Apr 2014

Keywords

  • colon
  • Crohn disease
  • idiopathic inflammatory bowel disease
  • microRNA
  • miR-31
  • next-generation sequencing
  • ulcerative colitis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medicine(all)

Fingerprint Dive into the research topics of 'Novel specific microRNA biomarkers in idiopathic inflammatory bowel disease unrelated to disease activity'. Together they form a unique fingerprint.

Cite this